<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23739715</article-id>
      <article-id pub-id-type="pmc">3750898</article-id>
      <article-id pub-id-type="doi">10.1590/S0365-05962013000200020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Marshall's syndrome<xref ref-type="fn" rid="fn01"><sup>*</sup></xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>S&#xED;ndrome de Marshall</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fontenelle</surname>
            <given-names>Elisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Almeida</surname>
            <given-names>Ana Paula Moura</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Gabriela Maria Assis de Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Dermatologist from the Fernandes Figueira Institute (Instituto Fernandes
Figueira) - FIOCRUZ &#x2013; Rio de Janeiro (RJ), Brazil </aff>
      <aff id="aff2"><label>2</label> Dermatologist from the Teaching Hospital Alvaro Alvim &#x2013; School of
Medicine of Campos (Hospital Escola &#xC1;lvaro Alvim - Faculdade de Medicina de Campos
(HEAA-FMC). Professor at the School of Medicine of Campos (Faculdade de Medicina de
Campos - FMC) &#x2013; Campos dos Goytacazes (RJ), Brazil </aff>
      <aff id="aff3"><label>3</label> Dermatologist of the Military Firefighters Corporation of the State of
Rio de Janeiro (Corpo de Bombeiros Militar do Estado do Rio de Janeiro - CBMERJ) &#x2013; Rio
de Janeiro (RJ), Brazil </aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Ana Paula Moura de Almeida - Rua Dr Ovidio Manh&#xE3;es, 156
- 28013-290, Campos dos Goytacazes - RJ - Brazil - E-mail:
<email>medpaula@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>2</issue>
      <fpage>279</fpage>
      <lpage>282</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Marshall&#xB4;s syndrome is a form of acquired cutis laxa without systemic involvement,
which is preceded by an inflammatory dermatitis with a neutrophilic component. We
report a case of a 6-year-old boy with clinical and histopathological features of
this syndrome. The etiology remains unknown and there is no definitive treatment.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>S&#xED;ndrome de Marshall &#xE9; uma forma de cutis laxa adquirida, sem envolvimento sist&#xEA;mico,
que &#xE9; precedida por uma dermatite inflamat&#xF3;ria com componente neutrof&#xED;lico. Relatamos
o caso de um menino de 6 anos de idade com as caracter&#xED;sticas cl&#xED;nicas e
histopatol&#xF3;gicas desta s&#xED;ndrome. A etiologia desta doen&#xE7;a permanece desconhecida e
ainda n&#xE3;o existe um tratamento definitivo. </p>
      </trans-abstract>
      <kwd-group>
        <kwd>Atrophy</kwd>
        <kwd>Cutis laxa</kwd>
        <kwd>Elastic tissue</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Marshall&#xB4;s syndrome is a rare pediatric skin disease characterized by urticarial or
papular eruption followed by acute destruction of elastic tissue, resulting in skin
atrophy and severe physical disfigurement. In 1966, Marshall, Heyl &amp; Weber, from
South Africa, described a disease in young children with characteristics resembling
those of anetoderma and cutis laxa, which they called "postinflammatory elastolysis and
cutis laxa" (PECL). The authors present the case of a child with clinical and
histophatological features of this syndrome, which resulted in decreased skin elasticity
and wrinkled skin.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 6-year-old boy, phototype IV, from Rio de Janeiro, Brazil, arrived at the Pediatric
Dermatology Service with infiltrated, well circumscribed erythematous and edematous
plaques with polycyclic configuration, on his face, back and extremities for two months,
associated with episodes of fever (<xref ref-type="fig" rid="f01">Figures 1</xref> and
<xref ref-type="fig" rid="f02">2</xref>). He had not taken any medication. Laboratory
studies revealed normal blood count values (except for a high eosinophils rate - 7%).
Serological reactions for syphilis (VDRL), HIV and baciloscopy were negative. Serum
&#x3B1;1antitrypsin was not available. A biopsy specimen obtained from one of the infiltrated
plaques showed a neutrophilic disease with edema of the dermal papillae and dense
neutrophilic dermal infiltrate (<xref ref-type="fig" rid="f03">Figure 3</xref>).
Treatment with Dapsone (1mg/Kg/day) and Prednisone (0.5mg/Kg/day) was initiated. All
inflammatory plaques resolved slowly and left atrophic, wrinkled areas, causing a
premature aging appearance (<xref ref-type="fig" rid="f04">Figure 4</xref>). A biopsy
specimen of the atrophic cutaneous areas showed decreased thickness of the reticular
dermis. Acid orcein staining showed marked decrease in the number of elastic fibers in
the reticular dermis. The existing fibers were shortened and fragmented, but collagen
appeared normal (<xref ref-type="fig" rid="f05">Figure 5</xref>). The patient evolved
with other recurrent episodes and, as a result, new wrinkled areas every time he failed
to follow treatment recommendations.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Clinic - Acute phase. Indurated well-circumscribed erythematous plaques on the
back</p>
        </caption>
        <graphic xlink:href="abd-88-0279-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Acute phase: Infiltrated erythematous and edematous plaques on the face, arm
and chest</p>
        </caption>
        <graphic xlink:href="abd-88-0279-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Histopathology - Acute phase. Hematoxylin-eosin 400X - Dense neutrophilic
dermal infiltrate with edema of the dermal papillae</p>
        </caption>
        <graphic xlink:href="abd-88-0279-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Clinic - Chronic phase: Atrophic, wrinkled areas on the back</p>
        </caption>
        <graphic xlink:href="abd-88-0279-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Histopathology - Chronic phase. Acid orcein staining (1000 X) - with a
decrease in the number of elastic fibers in the reticular dermis. The existing
fibers are shortned and fragmented</p>
        </caption>
        <graphic xlink:href="abd-88-0279-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Marshall&#xB4;s syndrome was first described by Marshall, Heyl and Weber in 1966, in a group
of five South African children who had acute erythematous, infiltrated papular
eruption.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Cutis laxa refers to a heterogenous group of diseases with the particular clinical
appearance of premature aging. This disorder of elastic tissue can either be inherited
or acquired. The inherited form can be autosomal dominant (which may have a delayed
onset), recessive or x-linked (both are present at birth). Acquired cutis laxa is rare
and can be subdivided into type I and II. Type I acquired cutis laxa can be either
generalized or localized and this form may occur at any age, although with usual onset
in adulthood. Most of the cases reported in the literature refer to the generalized form
of type I, which usually follows episodes of inflammatory dermatosis, hypersensitivity
reaction to insect bites or drugs, neoplastic disorders or in association with
particular diseases. Systemic involvement is common.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup> Type II, or Marshall's syndrome, is characterized by acute inflammatory skin
lesions with subsequent development of localized areas of elastolysis. This form is also
called "postinflammatory elastolysis and cutis laxa" and occurs more often in infancy or
childhood.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>The pathogenesis of acquired cutis laxa remains unknown, but a number of hypotheses have
been proposed. Elastic fibers are made up of two components: a microfibrillar component
and an amorphous one, in which the fibrils are embedded. Elastase acts on this amorphous
component, as microfibrils are susceptible to digestion by other enzymes such as trypsin
and pepsin. Alteration or partial destruction of the amorphous component of the elastic
tissue would affect skin tension and pulmonary compliance. Neutrophils are an important
source of elastase, in addition to the pancreas. One hypothesis suggests excessive
elastase activity as a result of large amounts of elastase being released by neutrophils
and macrophages close to elastic fibers in some patients with localized, acquired cutis
laxa.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup> Goltz et al postulated a dysfunction in elastase inhibitors with an abnormal
copper metabolism to explain the pathogenesis of the disease.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> The main elastase inhibitor is alpha 1 antitrypsin, which might prevent
proteolysis of pulmonary tissue. Patients with cutis laxa and pulmonary involvement have
shown low levels of this enzyme.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> Copper plays an important role in the formation of lysine polymers, which form
the crosslinkage bonds that result in the structural integrity of both elastic and
collagen fibers. Copper deficiencies lead to low lysyl oxidase activity and subsequent
failure of the mechanism of crosslinkage and elastolysis.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> An immunomediated mechanism has been also suspected.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>Marshall&#xB4;s disease starts at the age of 1-4 years, in previously healthy infants with a
negative family history. The course is prolonged and is characterized by a relapsing
acute inflammatory phase which lasts several months or years. Morphologically, the acute
phase consists of firm, erythematous, infiltrated lesions lasting about a week or
fortnight, often as rings with a collarette of scales or as diffuse plaques (or both
types together). The face and neck are affected in most of the cases but other skin
surfaces can also be affected. In these areas this results in decreased elasticity,
laxity and usually in mild atrophy. A senile or aged facial expression is
characteristic. In some cases, most of the body surface is involved.<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>The diagnosis is strongly suggested clinically, but requires histopathological
confirmation. The inflammatory phase shows capillary dilatation and a perivascular
infiltrate composed of neutrophils and eosinophils. A dermal edema can be present. In
the chronic phase, the most common finding is a marked reducti on of elastic fibers at
all levels of the skin with the residual fibers being fragmented and of irregular
thickness. Collagen fibers are usually normal.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>The main differential diagnosis of Marshall&#xB4;s syndrome includes anetoderma and mid
dermal elastolysis. Anetoderma is characterized by smaller lesions showing a herniation
at palpation, unlike Marshall&#xB4;s syndrome. Mid dermal elastolysis can be distinguished
from this syndrome based on the elastolysis pattern, which is confined to the mid
reticular dermis. Also, mid dermal elastolysis tends not to affect the face.<sup><xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
      <p>There is no satisfactory treatment for cutis laxa. Dapsone was given to patients in the
inflammatory phase and successfully controled swelling. However, it did not prevent
disease progression. Plastic surgical repair seems to be the only hope for these
patients in need of physical appearance improvement.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Study carried out at the Municipal Hospital Jesus (Hospital Municipal Jesus) - Rio
de Janeiro (RJ), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heyl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
          <article-title>A report on a new variety of this phenomenon and a
discussion of some syndromes characterized by elastolysis</article-title>
          <source>S Afr Med J</source>
          <year>1966</year>
          <volume>40</volume>
          <fpage>1016</fpage>
          <lpage>1022</lpage>
          <pub-id pub-id-type="pmid">5926113</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riveros</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Gavil&#xE1;n</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Fran&#xE7;a</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Sotto</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Acquired localized cutis laxa confined to the face: case
report and review of the literature</article-title>
          <source>Int J Dermatol</source>
          <year>2004</year>
          <volume>43</volume>
          <fpage>931</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="pmid">15569023</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reed</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Horowitz</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Beighton</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acquired cutis laxa: primary generalized
elastolysis</article-title>
          <source>Arch Dermatol</source>
          <year>1971</year>
          <volume>103</volume>
          <fpage>661</fpage>
          <lpage>669</lpage>
          <pub-id pub-id-type="pmid">5555855</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machet</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Machet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vaillant</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Est&#xE8;ve</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>de Muret</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arbeille</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Acquired localized cutis laxa due to cutaneous
lymphoplasmacytoid lymphoma</article-title>
          <source>Arch Dermatol</source>
          <year>1995</year>
          <volume>131</volume>
          <fpage>110</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">7826089</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machet</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Machet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vaillant</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Est&#xE8;ve</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>de Muret</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arbeille</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cutis laxa: a manifestation of generalized
elastolysis</article-title>
          <source>Arch Dermatol</source>
          <year>1965</year>
          <volume>92</volume>
          <fpage>373</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="pmid">5835325</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Hood</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Barnett</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Post-inflammatory elastolysis and cutis
laxa</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1990</year>
          <volume>22</volume>
          <fpage>40</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">2298964</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fornieri</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Quaglino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lungarella</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cavarra</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tiozzo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Giro</surname>
              <given-names>MG</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Elastin production and degradation in cutis laxa
acquisita</article-title>
          <source>J Invest Dermatol</source>
          <year>1989</year>
          <volume>93</volume>
          <fpage>147</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">2745999</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verhagen</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Woerdeman</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Post-inflammatory elastolysis and cutis
laxa</article-title>
          <source>Br J Dermatol</source>
          <year>1975</year>
          <volume>92</volume>
          <fpage>183</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">1148114</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nanko</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jepsen</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Zachariae</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>S&#xF8;gaard</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Acquired cutis laxa (generalized elastolysis): light and
electron microscopic studies</article-title>
          <source>Acta Dermatovener</source>
          <year>1979</year>
          <volume>59</volume>
          <fpage>315</fpage>
          <lpage>324</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Bercovitch</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dill</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Robinson-Bostom</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acquired disorders of elastic tissue: Part II. Decreased
elastic tissue</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2004</year>
          <volume>51</volume>
          <fpage>165</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="pmid">15280835</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
